Dr, Diabetes Trials Unit, OCDEM, University of Oxford, United Kingdom
Research Article
A Proof of Concept Study to Evaluate the Impact of an Established Telehealth Mood Monitoring System on Mood in Individuals with Type 2 Diabetes when Initiating an Injectable Therapy
Author(s): Olorunola Fatai Agbaje*, Rury Holman, Hermione Price, Jonathan Price, Guy Goodwin and John Geddes
Background: We aimed to determine the feasibility of using an established telehealth system to monitor potential mood changes in individuals with type 2 diabetes when commencing an injectable glucose-lowering therapy.
Methods: Individuals with type 2 diabetes commencing an injectable therapy as part of their routine clinical care when not achieving glycemic control on oral antidiabetic therapy, or when instituted as part of a randomized clinical trial, were asked to self monitor their mood for six months. Participants were asked to complete the Quick Inventory of Depressive Symptoms–Self Report (QIDS-SR) weekly and the Diabetes Distress Scale (DDS17) monthly.
Results: Seven participants were recruited who all initiated an injectable therapy and were followed up for median 33 (27–37) weeks. Median (IQR) .. View More»
